Amalgamated Bank trimmed its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 2.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,704 shares of the industrial products company’s stock after selling 958 shares during the period. Amalgamated Bank’s holdings in Xylem were worth $5,419,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp increased its position in Xylem by 1.9% in the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company’s stock worth $1,394,792,000 after purchasing an additional 189,820 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Xylem by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company’s stock worth $762,804,000 after buying an additional 54,877 shares in the last quarter. Impax Asset Management Group plc increased its holdings in shares of Xylem by 231.5% in the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company’s stock worth $644,039,000 after buying an additional 3,883,845 shares during the last quarter. Swedbank AB raised its position in shares of Xylem by 23.1% during the 4th quarter. Swedbank AB now owns 3,683,201 shares of the industrial products company’s stock valued at $427,325,000 after buying an additional 691,618 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Xylem by 1.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company’s stock valued at $465,760,000 after buying an additional 32,645 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several brokerages have weighed in on XYL. Royal Bank of Canada reduced their price objective on Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Stifel Nicolaus decreased their price target on Xylem from $166.00 to $150.00 and set a “buy” rating on the stock in a report on Friday, January 24th. TD Cowen dropped their price objective on shares of Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a research note on Wednesday, November 6th. Robert W. Baird increased their target price on shares of Xylem from $139.00 to $148.00 and gave the company an “outperform” rating in a research note on Wednesday, February 5th. Finally, Wolfe Research restated a “peer perform” rating on shares of Xylem in a report on Thursday, December 12th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $149.90.
Xylem Stock Up 0.4 %
Shares of XYL opened at $129.00 on Friday. The firm has a fifty day moving average price of $122.60 and a 200-day moving average price of $127.21. The company has a current ratio of 1.76, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $31.34 billion, a P/E ratio of 35.25, a P/E/G ratio of 2.33 and a beta of 1.07. Xylem Inc. has a 12-month low of $113.26 and a 12-month high of $146.08.
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.12 by $0.06. The company had revenue of $2.30 billion during the quarter, compared to analysts’ expectations of $2.18 billion. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.99 EPS. Equities research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Shareholders of record on Tuesday, February 18th will be issued a dividend of $0.40 per share. This is an increase from Xylem’s previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a yield of 1.24%. The ex-dividend date is Tuesday, February 18th. Xylem’s dividend payout ratio (DPR) is presently 43.72%.
Xylem Company Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also
- Five stocks we like better than Xylem
- 3 Small Caps With Big Return Potential
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- How to Find Undervalued Stocks
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.